Skip to Content


In the US, Claforan (cefotaxime systemic) is a member of the drug class third generation cephalosporins and is used to treat Bacteremia, Bone infection, Cesarean Section, CNS Infection, Endometritis, Epiglottitis, Gonococcal Infection - Disseminated, Gonococcal Infection - Uncomplicated, Intraabdominal Infection, Joint Infection, Kidney Infections, Lyme Disease, Lyme Disease - Arthritis, Lyme Disease - Carditis, Lyme Disease - Neurologic, Meningitis, Pelvic Inflammatory Disease, Peritonitis, Pneumonia, Salmonella Gastroenteritis, Sepsis, Septicemia, Skin or Soft Tissue Infection, Surgical Prophylaxis and Urinary Tract Infection.

US matches:

Ingredient matches for Claforan


Cefotaxime is reported as an ingredient of Claforan in the following countries:

  • Bangladesh
  • China
  • Cyprus
  • Egypt
  • India
  • Lebanon

Cefotaxime sodium (a derivative of Cefotaxime) is reported as an ingredient of Claforan in the following countries:

  • Belgium
  • Brazil
  • Canada
  • Georgia
  • Ireland
  • Israel
  • Japan
  • Oman
  • Russian Federation
  • Spain
  • Sweden
  • United States
  • Venezuela
  • Vietnam

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.